T1	Pharmacological_substance 10 33	2-Chloro-deoxyadenosine
N1000 	Reference T1 MeSH:D017338	2-Chloro-deoxyadenosine
T2	Disorder 72 91	Castleman's disease
N1 	Reference T2 UMLS:C0017531	Castleman's disease
T3	Disorder 133 155	non-Hodgkin's lymphoma
N2 	Reference T3 UMLS:C0024305	non-Hodgkin's lymphoma
T4	Disorder 261 293	multicentric Castleman's disease
N3 	Reference T4 UMLS:C0017531	multicentric Castleman's disease
T5	Disorder 295 298	MCD
N4 	Reference T5 UMLS:C1636149	MCD
T6	Pharmacological_substance 479 484	2-CdA
N1001 	Reference T6 MeSH:C036854	2-CdA
N1002 	Reference T6 MeSH:D017338	2-CdA
T7	Pharmacological_substance 486 509	2-chloro-deoxyadenosine
N1003 	Reference T7 MeSH:D017338	2-chloro-deoxyadenosine
T8	Disorder 547 550	MCD
N5 	Reference T8 UMLS:C1636149	MCD
T9	Disorder 711 733	non-Hodgkin's lymphoma
N6 	Reference T9 UMLS:C0024305	non-Hodgkin's lymphoma
T10	Disorder 735 738	NHL
N7 	Reference T10 UMLS:C0024305	NHL
T11	Disorder 741 770	diffuse large B-cell lymphoma
N8 	Reference T11 UMLS:C0079744	diffuse large B-cell lymphoma
T12	Pharmacological_substance 813 818	2-CdA
N1004 	Reference T12 MeSH:C036854	2-CdA
N1005 	Reference T12 MeSH:D017338	2-CdA
T15	Disorder 987 1006	secondary neoplasms
N9 	Reference T15 UMLS:C2939419	secondary neoplasms
T16	Disorder 1118 1121	MCD
N10 	Reference T16 UMLS:C1636149	MCD
T17	Pharmacological_substance 1201 1206	2-CdA
N1006 	Reference T17 MeSH:C036854	2-CdA
N1007 	Reference T17 MeSH:D017338	2-CdA
T19	Disorder 1244 1247	MCD
N11 	Reference T19 UMLS:C1636149	MCD
T20	Disorder 1251 1254	NHL
N12 	Reference T20 UMLS:C0024305	NHL
T21	Disorder 775 796	peripheral T-cell NHL
T13	Disorder 564 606	unresectable hyaline-vascular type disease
T23	Pharmacological_substance 1071 1076	2-CdA
N1008 	Reference T23 MeSH:C036854	2-CdA
N1009 	Reference T23 MeSH:D017338	2-CdA
T26	Disorder 860 876	immunodeficiency
N13 	Reference T26 UMLS:C0021051	immunodeficiency
T27	Subject 514 528	three patients
T28	Subject 530 533	two
T29	Subject 555 558	one
T31	Speculation_cue 1207 1210	may
T32	Disorder 885 903;917 937	profound influence on the immune system
T34	Speculation_cue 949 958	questions
T35	Speculation_cue 96 99	may
T36	Manner_cue 42 68	durable complete remission
T37	Disorder 216 253	unresectable hyaline-vascular variant
T38	Speculation_cue 1077 1080	can
T39	Manner_cue 1088 1114	durable complete remission
T40	Subject 1122 1130	patients
T41	Negation_cue 1152 1163	cannot cure
